The Distribution and ‘In Vivo’ Phase Variation Status of Haemoglobin Receptors in Invasive Meningococcal Serogroup B Disease: Genotypic and Phenotypic Analysis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Two haemoglobin-binding proteins, HmbR and HpuAB, contribute to iron acquisition by Neisseria meningitidis. These receptors are subject to high frequency, reversible switches in gene expression--phase variation (PV)--due to mutations in homopolymeric (poly-G) repeats present in the open reading frame. The distribution and PV state of these receptors was assessed for a representative collection of isolates from invasive meningococcal disease patients of England, Wales and Northern Ireland. Most of the major clonal complexes had only the HmbR receptor whilst the recently expanding ST-275-centred cluster of the ST-269 clonal complex had both receptors. At least one of the receptors was in an 'ON' configuration in 76.3% of the isolates, a finding that was largely consistent with phenotypic analyses. As PV status may change during isolation and culture of meningococci, a PCR-based protocol was utilised to confirm the expression status of the receptors within contemporaneously acquired clinical specimens (blood/cerebrospinal fluid) from the respective patients. The expression state was confirmed for all isolate/specimen pairs with <15 tract repeats indicating that the PV status of these receptors is stable during isolation. This study therefore establishes a protocol for determining in vivo PV status to aid in determining the contributions of phase variable genes to invasive meningococcal disease. Furthermore, the results of the study support a putative but non-essential role of the meningococcal haemoglobin receptors as virulence factors whilst further highlighting their vaccine candidacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“N. meningitidis serotype B isolates associated with disease also exhibit “on” phase variation of HmbR”
From Heme Synthesis and Acquisition in Bacterial Pathogens (2016) · cites this paper as [208]
In the citing paper
“correlating virulence with the expression of HmbR [208].”
From Heme Synthesis and Acquisition in Bacterial Pathogens (2016) · cites this paper as [208]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maiden, M. C. J., Bygraves, J. A., Feil, E., Morelli, G., Russell, J. E., Urwin, R., Zhang, Q., Zhou, J., Zurth, K., Caugant, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3140 · Cited by 3,833 · cited 3×
“Tauseef et al. [16] utilised 90 IMD strains from the strain panel used to evaluate multilocus sequence typing (MLST) [23].”
MethodSelf-citationSierra, G. V. G., Campa, H. C., Varcacel, N. M., Garcia, I. L., Izquierdo, P., Sotolongo, P. F., Casanueva, G. V., Rico, C. O., Rodriguez, C. R., & Terry, M. H. (1991) · PubMed · Cited by 512
Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines
Wyle, F. A., Artenstein, M. S., Brandt, B. L., Tramont, E. C., Kasper, D. L., Altieri, P. L., Berman, S. L., & Lowenthal, J. P. (1972) · Journal of Infectious Diseases · doi:10.1093/infdis/126.5.514 · Cited by 446 · cited 1×
“The polysaccharide of serogroup B meningococci (MenB), a leading cause of IMD in industrialized nations, is poorly immunogenic in humans [4].”
BackgroundThe Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica
Cartwright, K. A. V., Stuart, J. M., Jones, D. M., & Noah, N. D. (1987) · Epidemiology and Infection · doi:10.1017/s0950268800066449 · Cited by 421 · cited 1×
“Neisseria meningitidis (the meningococcus) is a commensal of the human nasopharynx with an overall prevalence of approximately 10% [1].”
BackgroundSerruto, D., Bottomley, M. J., Ram, S., Giuliani, M. M., & Rappuoli, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.033 · Cited by 404 · cited 1×
“Such a need for multiple antigens or antigenic variants has been demonstrated for other subcapsular antigens, including those of the recently licensed 4CMenB vaccine [34] or Pfizer’s investigational bivalent recombinant fHbp vaccine [8].”
BackgroundMadico, G., Welsch, J. A., Lewis, L. A., McNaughton, A., Perlman, D. H., Costello, C. E., Ngampasutadol, J., Vogel, U., Granoff, D. M., & Ram, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.501 · Cited by 390 · cited 1×
“Other MenB vaccines have not focused on potential redundancy-mediated escape in this way [27,28].”
BackgroundVogel, U., Taha, M.-K., Vazquez, J. A., Findlow, J., Claus, H., Stefanelli, P., Caugant, D. A., Kriz, P., Abad, R., Bambini, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70006-9 · Cited by 285 · cited 1×
“Universal vaccine coverage of MenB is, however, yet to be achieved [9].”
BackgroundSelf-citationGray, S. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46288-0 · Cited by 221 · cited 1×
“35 [20] were excluded from the study in order to maximise the ability to detect the Hb receptor genes.”
BackgroundSelf-citationJiang, H.-Q., Hoiseth, S. K., Harris, S. L., McNeil, L. K., Zhu, D., Tan, C., Scott, A. A., Alexander, K., Mason, K., Miller, L., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.083 · Cited by 198 · cited 1×
“Such a need for multiple antigens or antigenic variants has been demonstrated for other subcapsular antigens, including those of the recently licensed 4CMenB vaccine [34] or Pfizer’s investigational bivalent recombinant fHbp vaccine [8].”
BackgroundThe Neisseria meningitidis haemoglobin receptor: its role in iron utilization and virulence
Stojijkovic, I., Hwa, V., de Saint Martin, L., O'Gaora, P., Nassif, X., Heffron, F., & So, M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02266.x · Cited by 188 · cited 1×
“The TonB dependent HmbR and HpuAB systems are each able to bind Hb, whilst the latter also binds the Hb-haptoglobin complex [12,13].”
BackgroundIron Transport Systems in Neisseria meningitidis
Perkins-Balding, D., Ratliff-Griffin, M., & Stojiljkovic, I. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.1.154-171.2004 · Cited by 172 · cited 5×
“Given the necessity of iron for IMD [10], however, a vaccine containing HmbR, HpuA and TbpB as its primary components might circumvent any redundancy in iron uptake mechanisms within the bloodstream.”
BackgroundInfluentialMeningococcal disease: changes in epidemiology and prevention
Stephens, D. S., Chang, Q., & Tzeng (2012) · Clinical Epidemiology · doi:10.2147/clep.s28410 · Cited by 167 · cited 1×
“It is a leading cause of meningitis and septicaemia globally and is associated with significant morbidity and mortality [2].”
BackgroundThe simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis
Bayliss, C. D., Field, D., & Moxon, E. R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12557 · Cited by 160 · cited 9×
“The absence of either receptor in the ON state was confirmed for 22.5% (18/80) of the isolates whilst a further 1.3% (1/80) were genotypically OFF but phenotypically indeterminate.”
BackgroundSelf-citationLewis, L. A., Ngampasutadol, J., Wallace, R., Reid, J. E. A., Vogel, U., & Ram, S. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001027 · Cited by 159 · cited 1×
“Other MenB vaccines have not focused on potential redundancy-mediated escape in this way [27,28].”
BackgroundLewis, L. A., Gray, E., Wang, Y., Roe, B. A., & Dyer, D. W. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2501619.x · Cited by 145 · cited 1×
“85 (rev) GGGAAACGCTTGGGCGATGG [36]”
Danve, B., Lissolo, L., Mignon, M., Dumas, P., Colombani, S., Schryvers, A. B., & Quentin-Millet, M. J. (1993) · Vaccine · doi:10.1016/0264-410x(93)90045-y · Cited by 128 · cited 1×
“1 antigenic variant for broad protection [30-33].”
Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand
Arnold, R., Galloway, Y., McNicholas, A., & O’Hallahan, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.120 · Cited by 113 · cited 1×
“MenB vaccine development has largely, therefore, focused upon sub-capsular antigens [2,5–9].”
BackgroundEnhancement of Neisseria meningitidis infection in mice by addition of iron bound to transferrin
Holbein, B. E. (1981) · Infection and Immunity · doi:10.1128/iai.34.1.120-125.1981 · Cited by 109 · cited 1×
“As addition of free iron or transferrin is required to establish IMD in mouse models of infection [11], these receptors constitute potential virulence factors.”
BackgroundRecombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles
Bai, X., Findlow, J., & Borrow, R. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.585965 · Cited by 106 · cited 1×
“MenB vaccine development has largely, therefore, focused upon sub-capsular antigens [2,5–9].”
BackgroundSelf-citationMartin, P., Van De Ven, T., Mouchel, N., Jeffries, A. C., Hood, D. W., & Moxon, E. R. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03678.x · Cited by 102 · cited 1×
“hmbR-RF4 (rev) GCTACTGAACACGTCGTTCC [35]”
Weynants, V. E., Feron, C. M., Goraj, K. K., Bos, M. P., Denoël, P. A., Verlant, V. G., Tommassen, J., Peak, I. R. A., Judd, R. C., Jennings, M. P., et al. (2007) · Infection and Immunity · doi:10.1128/iai.00411-07 · Cited by 96 · cited 1×
“1 antigenic variant for broad protection [30-33].”
Phase variation of HpuAB and HmbR, two distinct haemoglobin receptors of Neisseria meningitidis DNM2
Lewis, L. A., Gipson, M., Hartman, K., Ownbey, T., Vaughn, J., & Dyer, D. W. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01409.x · Cited by 95 · cited 1×
“Both systems undergo phase variation (PV) owing to homopolymeric (poly-G) tracts in the open reading frames of hmbR and hpuA [14].”
BackgroundAla'Aldeen, D. A., Stevenson, P., Griffiths, E., Gorringe, A. R., Irons, L. I., Robinson, A., Hyde, S., & Borriello, S. P. (1994) · Infection and Immunity · doi:10.1128/iai.62.7.2984-2990.1994 · Cited by 94
Lucidarme, J., Comanducci, M., Findlow, J., Gray, S. J., Kaczmarski, E. B., Guiver, M., Kugelberg, E., Vallely, P. J., Oster, P., Pizza, M., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00936-09 · Cited by 90 · cited 1×
“Isolates were cultured overnight on Columbia agar plus 5% horse blood prior to DNA extraction as previously described [21].”
MethodSelf-citationQuadrivalent meningococcal conjugate vaccines
Pace, D., Pollard, A. J., & Messonnier, N. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.003 · Cited by 69
Bidmos, F. A., Neal, K. R., Oldfield, N. J., Turner, D. P. J., Ala'Aldeen, D. A. A., & Bayliss, C. D. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01322-10 · Cited by 68 · cited 4×
“However, the carriage isolates previously described were obtained from a localised study of first year university students and included few MenB isolates and multiple isolates arising from clonal expansion [25].”
BackgroundSelf-citationRokbi, B., Renauld‐Mongénie, G., Mignon, M., Danve, B., Poncet, D., Chabanel, C., Caugant, D. A., & Quentin-Millet, M. J. (2000) · Infection and Immunity · doi:10.1128/iai.68.9.4938-4947.2000 · Cited by 57 · cited 1×
“1 antigenic variant for broad protection [30-33].”
Genotypic and Phenotypic Modifications of Neisseria meningitidis after an Accidental Human Passage
Omer, H., Rose, G., Jolley, K. A., Frapy, E., Zahar, J.-R., Maiden, M. C. J., Bentley, S. D., Tinsley, C. R., Nassif, X., & Bille, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017145 · Cited by 55 · cited 1×
“Preferential selection of HpuAB over HmbR has previously been noted during a laboratory acquired meningococcal infection in which the preinfection organism (hmbr:hpuA) was ON for hmbR and OFF for hpuA [24].”
BackgroundTauseef, I., Harrison, O. B., Wooldridge, K. G., Feavers, I. M., Neal, K. R., Gray, S. J., Kriz, P., Turner, D. P. J., Ala’Aldeen, D. A. A., Maiden, M. C. J., et al. (2011) · Microbiology · doi:10.1099/mic.0.046946-0 · Cited by 51 · cited 13×
“Consistent with previous findings [16,17], hmbR (either alone or in conjunction with hpuA) was highly represented among these IMD isolates (present in 95%) whilst the presence of hpuA as the sole receptor was rare (5%).”
BackgroundMethodResultSelf-citationRohde, K. H., & Dyer, D. W. (2004) · Infection and Immunity · doi:10.1128/iai.72.5.2494-2506.2004 · Cited by 47
Epidemiological Evidence for the Role of the Hemoglobin Receptor, HmbR, in Meningococcal Virulence
Harrison, O. B., Evans, N. J., Blair, J. M., Grimes, H. S., Tinsley, C. R., Nassif, X., Kriz, P., Ure, R., Gray, S. J., Derrick, J. P., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/599377 · Cited by 36 · cited 3×
“These receptors are variably distributed among meningococci, with an overrepresentation of hmbR, and underrepresentation of the hpuAB-only genotype among IMD isolates [15,16].”
BackgroundSelf-citationPintor, M. (1996) · Microbial Pathogenesis · doi:10.1006/mpat.1996.0012 · Cited by 25 · cited 1×
“A further benefit to a vaccine incorporating HmbR, HpuA and TbpB is that non-bactericidal antibodies against these receptors may interfere with the process of iron uptake, thereby abrogating virulence [29].”
BackgroundRiepsamen, A. H., Gibson, T., Rowe, J. A., Chitwood, D. J., Subbotin, S. A., & Dowton, M. (2010) · Journal of Molecular Evolution · doi:10.1007/s00239-010-9414-3 · Cited by 18
Variation and molecular evolution of HmbR, the Neisseria meningitidis haemoglobin receptor
Evans, N. J., Harrison, O. B., Clow, K., Derrick, J. P., Feavers, I. M., & Maiden, M. C. J. (2010) · Microbiology · doi:10.1099/mic.0.036475-0 · Cited by 18 · cited 2×
“Consistent with previous findings [16,17], hmbR (either alone or in conjunction with hpuA) was highly represented among these IMD isolates (present in 95%) whilst the presence of hpuA as the sole receptor was rare (5%).”
BackgroundResultSelf-citationPoint Mutations in HpuB Enable Gonococcal HpuA Deletion Mutants To Grow on Hemoglobin
Chen, C.-J., Mclean, D., Thomas, C. E., Anderson, J. E., & Sparling, P. F. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.2.420-426.2002 · Cited by 16 · cited 1×
“A caveat to this is the prospect that mutants may escape by bypassing the need for the lipoprotein components of the respective systems (HpuA and TbpB) for sufficient iron acquisition [26]; the use of several antigenic components would, nonetheless, reduce the likelihood of vaccine escape.”
Background
Research works printed but not linked: 1
- Lucidarme J (2012) Ph.D. thesis. Potential coverage of an investigational, multicomponent, meningococcal vaccine with a focus on the ST-269 clonal complex. University of Manchester, Manchester, United Kingdom.
Cited by
Heme Synthesis and Acquisition in Bacterial Pathogens
Choby, J. E., & Skaar, E. P. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.03.018 · Cited by 343
Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis
Caugant, D. A., & Brynildsrud, O. B. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0282-6 · Cited by 134
Phase-variable bacterial loci: how bacteria gamble to maximise fitness in changing environments
Phillips, Z. N., Tram, G., Seib, K. L., & Atack, J. M. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180633 · Cited by 104
An Overview of Neisseria meningitidis
Hollingshead, S., & Tang, C. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9202-7_1 · Cited by 59
Subversion of nutritional immunity by the pathogenic Neisseriae
Cornelissen, C. N. (2018) · Pathogens and Disease · doi:10.1093/femspd/ftx112 · Cited by 49
Metadata
- Authors
- Lucidarme, J., Findlow, J., Chan, H., Feavers, I. M., Gray, S. J., Kaczmarski, E. B., Parkhill, J., Bai, X., Borrow, R., & Bayliss, C. D.
- Affiliations
- Public Health England (GB)
- National Institute for Biological Standards and Control (GB)
- Wellcome Sanger Institute (GB)
- University of Leicester (GB)
- Corresponding author
- Lucidarme, Jay
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-30
- Volume
- 8
- Issue
- 9
- Pages
- e76932
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3786947
- OpenAlex
- W2028189542
- Cited by
- 21
- References
- 35
- Citations by year
- 2026: 1 · 2025: 1 · 2022: 2 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 2
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Meningitis Research Foundation
- University of Oxford
- Public Health England
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Keywords
- Neisseria meningitidis serogroup B, invasive meningococcal disease, phase variation, iron acquisition, virulence factors
- MeSH terms
- Bacterial Outer Membrane Proteins, Bacterial Proteins, Genotype, United Kingdom, Hemoglobins, Humans, Iron, Meningitis, Meningococcal, Phenotype, Receptors, Cell Surface, Gene Expression Regulation, Bacterial, Sequence Analysis, DNA, Virulence Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.